SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Total revenue for the quarter ended June 2022 of  Rs. 514.00 millions remain, more or less, the same.A slender decline of -28.35% was recorded to Rs. 38.67  millions from Rs. 53.97 millions in the corresponding previous quarter.Operating profit for the quarter ended June 2022 decreased to 64.66 millions as compared to 83.29 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 514.00 512.69 0.26 514.00 512.69 0.26 2196.63 2448.05 -10.27
Other Income 29.80 13.31 123.89 29.80 13.31 123.89 119.93 71.41 67.95
PBIDT 64.66 83.29 -22.37 64.66 83.29 -22.37 314.56 449.80 -30.07
Interest 5.04 1.89 166.67 5.04 1.89 166.67 13.55 2.71 400.00
PBDT 59.62 81.75 -27.07 59.62 81.75 -27.07 301.25 447.39 -32.67
Depreciation 9.95 9.71 2.47 9.95 9.71 2.47 39.48 40.35 -2.16
PBT 49.67 72.04 -31.05 49.67 72.04 -31.05 261.77 407.04 -35.69
TAX 11.00 18.07 -39.13 11.00 18.07 -39.13 63.86 115.32 -44.62
Deferred Tax 0.70 -0.06 -1266.67 0.70 -0.06 -1266.67 1.40 2.31 -39.39
PAT 38.67 53.97 -28.35 38.67 53.97 -28.35 197.91 291.72 -32.16
Equity 940.00 789.95 18.99 940.00 789.95 18.99 862.45 789.95 9.18
PBIDTM(%) 12.58 16.25 -22.57 12.58 16.25 -22.57 14.32 18.37 -22.06

Syncom Formulations Share Price

14.29 0.41 (2.95%)
12-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.25
Dr. Reddys Lab 1273.90
Cipla 1388.80
Zydus Lifesciences 1104.35
Lupin 2292.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: